European Environmentally Related Tax Revenue from Taxes on Energy in Manufacturing of Basic Pharmaceutical Products and Pharmaceutical Preparations Share by Country (Million US Dollars PPP = 2015)

The analysis of the 2023 European Environmentally Related Tax Revenue from energy taxes in the pharmaceutical manufacturing sector shows that Switzerland, the United Kingdom, and Spain lead in revenue, with notable share values. Switzerland and the United Kingdom demonstrated positive growth, with increases of 2.93% and 4.07% respectively. Conversely, Spain experienced a slight decrease of 0.054%. Greece saw strong growth at 6.25%, whereas Ireland faced a significant downturn with a decrease of 9.06%. Other countries, such as Latvia and Iceland, also faced declines of 15.33% and 3.62%, respectively.

Looking forward, key trends to watch include potential policy shifts towards greener technologies and their impact on tax revenue, the effect of economic growth variations on the pharmaceutical sector's energy consumption, and country-specific initiatives aimed at improving energy efficiency. These factors could significantly influence the energy tax landscape across Europe in the coming years.